Metraipolis › archive › dc_17e4e4ff83a8

Can the Development of Orphan Drugs Include Wider Patient Engagement? A Citizens' Jury to Explore a Promissory Notion — Europe PMC PMID:41347535

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41347535
DOI
10.1111/hex.70524
License (as archived)
solo-consultazione
Archived
2026-10-06T08:36:31.395Z
SHA-256 of the archived text
d19ff4583ef9b31f601f1f64eef60c3a989be91551469448ced783c93ca91ffb
Stable URL of this page
https://metraipolis.com/documento/dc_17e4e4ff83a8

How to cite

Can the Development of Orphan Drugs Include Wider Patient Engagement? A Citizens' Jury to Explore a Promissory Notion — Europe PMC PMID:41347535 — Europe PMC (en), https://europepmc.org/article/MED/41347535 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_17e4e4ff83a8 (Metraipolis archive dc_17e4e4ff83a8, sha256 d19ff4583ef9b31f601f1f64eef60c3a989be91551469448ced783c93ca91ffb)
BibTeX
@misc{dc17e4e4ff83a8,
  title = {Can the Development of Orphan Drugs Include Wider Patient Engagement? A Citizens' Jury to Explore a Promissory Notion — Europe PMC PMID:41347535},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41347535},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_17e4e4ff83a8; sha256 d19ff4583ef9b31f601f1f64eef60c3a989be91551469448ced783c93ca91ffb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41347535. Agents can read the archived copy with the MCP tool read_document.